![Steven Bellon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Bellon
Chief Tech/Sci/R&D Officer at
FOGHORN THERAPEUTICS INC.
Net worth: 650 376 $ as of 31/05/2026
Profile
Steven F.
Bellon is Chief Scientific Officer at Foghorn Therapeutics, Inc. since 2022.
Dr. Bellon was Executive Director & Head-Structural Biology at Constellation Pharmaceuticals, Inc. from 2008 to 2016.
Dr. Bellon earned a doctorate from Massachusetts Institute of Technology in 1992 and an undergraduate degree from Haverford College in 1987.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/04/2026 | 1,51,957 ( 0.26% ) | 650 376 $ | 31/05/2026 |
Steven Bellon active positions
| Companies | Position | Start |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 10/01/2022 |
Former positions of Steven Bellon
| Companies | Position | End |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Director/Board Member | 01/05/2016 |
Training of Steven Bellon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Haverford College
 Haverford College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
- Stock Market
- Insiders
- Steven Bellon
Choose MarketScreener 
